Hainan Honz Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Honz Pharmaceutical Company Limited with three other
companies in this sector in China:
Chengdu Taihe Health Technology Group Inc Ltd
sales of 462.75 million Chinese Renmimbi [US$68.24 million]
of which 84%
was Medicine Manufacturing),
Sinovac Biotech Ltd
(423.91 million Chinese Renmimbi [US$62.51 million]
of which 73%
was Inactivated hepatitis vaccines), and
Furen Pharmaceutical Group Industry Co Ltd
(462.06 million Chinese Renmimbi [US$68.14 million]
of which 100%
During the year ended December of 2015, sales at
Hainan Honz Pharmaceutical Company Limited were 409.59 million Chinese Renmimbi (US$60.40 million).
a very small
increase of 0.3%
versus 2014, when the company's sales were 408.39 million Chinese Renmimbi.